Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Toripalimab Combined With Anlotinib for Patients With Advanced, Relapsed, or Refractory Gastric, or Esophagogastric Junction Cancer (EGJC)

The Affiliated Hospital of Qingdao University · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
advanced
gastric or gastro-oesophageal junction carcinoma, advanced, relapsed gastric or gastro-oesophageal junction carcinoma, second-line therapy, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 838606
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.